ARCHIVES

Bosutinib Vs. Imatinib Study Didn’t Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

ACR Defends Mammographic Exams For Women 35-40,Says Carcinogenic Threat Is “Small”

July 30, 1976

In Brief: Lame Ducks continue On NCAB; Calabresi Elected To IOM; Ravikumar Moves To Yale

September 28, 1990

DeVita Losing Patience, Responds To Powers Letter

May 6, 1983

NCI, Komen Foundation Fund Summit meeting On Breast Cancer

October 8, 1993

Funding Opportunities.

April 19, 2002

Specter Remains Chairman Of Labor-HHS Subcommittee.

February 2, 2001